Benitec Biopharma Limited (NASDAQ:BNTC – Get Free Report) Director Suvretta Capital Management, L bought 16,384 shares of the business’s stock in a transaction dated Friday, December 19th. The shares were bought at an average cost of $11.48 per share, for a total transaction of $188,088.32. Following the transaction, the director owned 9,560,825 shares in the […]